查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601070

微流體市場：按材料、組件、應用和最終用戶分類 - 2025-2030 年全球預測

Microfluidics Market by Material (Glass-based, Polymer-based, Silicon-based), Component (Micro Needle, Micro Pump, Microfluidic Chip), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年微流體市場價值為255.3億美元，預計到2024年將達到318.4億美元，複合年成長率為25.37%，預計到2030年將達到1243.1億美元。

微流體是工程、物理、化學、生物化學、奈米技術和生物技術交叉領域的跨學科領域，涉及微通道內少量流體的操縱。其範圍涵蓋多種應用，包括藥物開發、臨床診斷和環境監測，為醫療保健、製藥和環境科學等產業做出貢獻。微流體的需求在於能夠以減少的樣品和試劑體積執行高效且經濟高效的分析，並提供快速結果。它們的應用範圍廣泛，但在醫療保健服務分散化和快速診斷需求不斷成長的推動下，它們在就地檢驗、病原體檢測和個人化醫療方面尤其重要。

主要市場統計
基準年[2023] 255.3億美元
預測年份 [2024] 318.4億美元
預測年份 [2030] 1243.1億美元
複合年成長率（%） 25.37%

影響微流體市場的主要成長要素包括微型化技術的進步、研發資金的增加以及需要創新診斷解決方案的慢性疾病盛行率的上升。微流體與人工智慧和機器學習的整合帶來了巨大的商機，特別是在智慧和自主實驗室晶片設備的開發方面。為了利用這些機會，相關人員應專注於跨學科合作並擴大其自動化數位化能力。

然而，設備高成本、製造流程複雜、監管要求嚴格等挑戰可能會阻礙市場成長。克服這些限制需要對擴充性的製造技術進行策略性投資並簡化監管途徑。需要創新的領域包括開發用於家庭醫療環境的低成本、易於使用的微流體系統，以及探索新材料，例如紙基微流體，以實現永續性和降低成本。

微流體市場以技術創新快、競爭激烈為特點，可望實現顯著成長。公司應致力於策略併購，以加強產品系列和地理覆蓋範圍。隨著對可攜式快速診斷解決方案的需求增加，專注於開拓具有更高靈敏度和特異性的整合系統將幫助您在不斷變化的市場環境中佔據主導。

市場動態：揭示快速發展的微流體市場的關鍵市場洞察

供需的動態交互作用正在改變微流體市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性病盛行率不斷上升，對就地檢驗的需求增加
    • 微流體晶片的小型化提高了設備的便攜性並減少了分析時間
    • 使用微流體進行藥物傳遞的應用的可能性
  • 市場限制因素
    • 複雜而漫長的監管核准流程
  • 市場機會
    • 開發基於微流體的 3D 細胞培養系統，例如晶片器官
    • 用於生物醫學分析和診斷的微流體組件的進展
  • 市場挑戰
    • 微流體與現有工作流程的整合

波特五力：駕馭微流體市場的戰略工具

波特的五力框架是了解微流體市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解微流體市場的外部影響

外部宏觀環境因素在塑造微流體市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解微流體市場的競爭格局

對微流體市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣微流體市場供應商績效評估

FPNV定位矩陣是評估微流體市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病的增加和對就地檢驗的需求
      • 微流體晶片的小型化提高了設備的便攜性並縮短了分析週轉時間
      • 使用微流體進行藥物傳輸的潛在應用
    • 抑制因素
      • 複雜而漫長的監管核准流程
    • 機會
      • 開發基於微流體的 3D 細胞培養系統，例如器官晶片
      • 用於生物醫學分析和診斷的微流體組件的進展
    • 任務
      • 微流體與現有工作流程的整合
  • 市場區隔分析
    • 材料：微流體裝置中玻璃和矽基材料的使用增加
    • 組成部分：採用微針和幫浦以最大限度地降低感染風險
    • 應用：微流體裝置在 IVD 與治療上的重要應用
    • 最終使用者：微流體在研究機構、醫院和診斷中心的新用途
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境
  • 客戶客製化

第6章微流體市場：依材料分類

  • 玻璃底座
  • 聚合物基
  • 矽膠底座

第7章微流體市場：依組成部分

  • 微型針
  • 微型幫浦
  • 微流體晶片

第8章微流體市場：依應用分類

  • 體外診斷
    • 臨床診斷
    • 就地檢驗
    • 獸醫診斷
  • 製藥與生命科學研究
    • 實驗室分析
      • 毛細管電泳
      • 基於細胞的檢測
      • 基因組分析
      • 蛋白質體分析
    • 微量點膠
    • 微反應
  • 治療藥物
    • 藥物輸送
    • 穿戴式裝置

第 9 章微流體市場：依最終用戶分類

  • 學術研究所
  • 醫院和診斷中心
  • 製藥和生物技術公司

第10章美洲微流體市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區微流體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲微流體市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Astravaeus 在種子輪融資中籌集了 1,650 萬歐元，以推進自動化微流體細胞和基因治療製造平台的開發
    • Biotechne 將收購瑞士空間生物學公司 Lunaphor
    • CellFE 宣佈在 ASGCT 2023 年會上展示新的微流體細胞工程平台

公司名單

  • Abbott Laboratories
  • Ascent Bio-Nano Technologies, Inc.
  • Camozzi Automation SpA
  • Dolomite Microfluidics
  • IMT Masks and Divisions AG
  • PerkinElmer Inc.
  • Thermo Fisher Scientific, Inc.
  • Mission Bio, Inc.
  • Idex Corporation
  • NanoCellect Biomedical.
  • Abaxis, Inc.
  • Quidel Corporation
  • Koninklijke Philips NV
  • Parker-Hannifin Corporation
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioFluidica
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Biosurfit SA
  • SMC Corporation
  • Micropoint Bioscience, Inc.
  • Fluigent SA
  • Elvesys Group
  • Achira Labs Pvt. Ltd.
  • Sphere Fluidics Limited
  • OPKO Health, Inc.
  • Cellix Limited
  • AbCellera Biologics Inc.
  • Fluidigm Corporation by Standard BioTools Inc.
Product Code: MRR-036C5CF3A81A

The Microfluidics Market was valued at USD 25.53 billion in 2023, expected to reach USD 31.84 billion in 2024, and is projected to grow at a CAGR of 25.37%, to USD 124.31 billion by 2030.

Microfluidics, a multidisciplinary field intersecting engineering, physics, chemistry, biochemistry, nanotechnology, and biotechnology, involves the manipulation of small volumes of fluids in micro-channels. Its scope extends across various applications such as drug development, clinical diagnostics, and environmental monitoring, serving industries including healthcare, pharmaceuticals, and environmental science. The necessity of microfluidics arises from its ability to conduct high-efficiency, cost-effective analyses with reduced sample and reagent volumes, thus providing rapid results. Its applications are broad but are particularly pivotal in point-of-care testing, pathogen detection, and personalized medicine, driven by the growing demand for decentralizing healthcare services and rapid diagnostics.

KEY MARKET STATISTICS
Base Year [2023] USD 25.53 billion
Estimated Year [2024] USD 31.84 billion
Forecast Year [2030] USD 124.31 billion
CAGR (%) 25.37%

Key growth factors influencing the microfluidics market include advancements in miniaturization technologies, increased funding for research and development, and the rising prevalence of chronic diseases necessitating innovative diagnostic solutions. The integration of microfluidics with AI and machine learning presents substantial opportunities, especially in developing smart, autonomous lab-on-a-chip devices. To capitalize on these opportunities, stakeholders should focus on interdisciplinary collaborations and expanding capabilities in automation and digitization.

However, challenges such as the high cost of devices, complex manufacturing processes, and stringent regulatory requirements can impede market growth. Overcoming these limitations will require strategic investments in scalable manufacturing technologies and streamlined regulatory pathways. Areas ripe for innovation include developing low-cost, user-friendly microfluidics systems for home healthcare settings, and exploring new materials like paper-based microfluidics for sustainability and cost reduction.

The microfluidics market, characterized by rapid technological advancements and a high degree of competition, offers substantial growth prospects. Companies should target strategic mergers and acquisitions to enhance their product portfolios and geographical reach. Insights indicate that as the demand for portable and rapid diagnostic solutions increases, emphasizing the development of integrated systems with enhanced sensitivity and specificity can position businesses for leadership in this evolving market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Microfluidics Market

The Microfluidics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
    • Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
    • Potential Applications of Drug Delivery using Microfluidics
  • Market Restraints
    • Complicated and Time-Consuming Regulatory Approval Process
  • Market Opportunities
    • Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
    • Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
  • Market Challenges
    • Integration of Microfluidics with Existing Workflows

Porter's Five Forces: A Strategic Tool for Navigating the Microfluidics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Microfluidics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Microfluidics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Microfluidics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Microfluidics Market

A detailed market share analysis in the Microfluidics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Microfluidics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Microfluidics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Microfluidics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ascent Bio-Nano Technologies, Inc., Camozzi Automation S.p.A., Dolomite Microfluidics, IMT Masks and Divisions AG, PerkinElmer Inc., Thermo Fisher Scientific, Inc., Mission Bio, Inc., Idex Corporation, NanoCellect Biomedical., Abaxis, Inc., Quidel Corporation, Koninklijke Philips N.V., Parker-Hannifin Corporation, Illumina, Inc., Bio-Rad Laboratories, Inc., BioFluidica, Agilent Technologies, Inc., Danaher Corporation, Biosurfit SA, SMC Corporation, Micropoint Bioscience, Inc., Fluigent S.A., Elvesys Group, Achira Labs Pvt. Ltd., Sphere Fluidics Limited, OPKO Health, Inc., Cellix Limited, AbCellera Biologics Inc., and Fluidigm Corporation by Standard BioTools Inc..

Market Segmentation & Coverage

This research report categorizes the Microfluidics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Material, market is studied across Glass-based, Polymer-based, and Silicon-based.
  • Based on Component, market is studied across Micro Needle, Micro Pump, and Microfluidic Chip.
  • Based on Application, market is studied across In-Vitro Diagnostics, Pharmaceutical & Life Science Research, and Therapeutics. The In-Vitro Diagnostics is further studied across Clinical Diagnostics, Point-Of-Care Testing, and Veterinary Diagnostics. The Pharmaceutical & Life Science Research is further studied across Lab Analytics, Microdispensing, and Microreaction. The Lab Analytics is further studied across Capillary Electrophoresis, Cell-based Assays, Genomic analysis, and Proteomic Analysis. The Therapeutics is further studied across Drug Delivery and Wearable Devices.
  • Based on End User, market is studied across Academic & Research Institutes, Hospitals & Diagnostic Centers, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
      • 5.1.1.2. Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
      • 5.1.1.3. Potential Applications of Drug Delivery using Microfluidics
    • 5.1.2. Restraints
      • 5.1.2.1. Complicated and Time-Consuming Regulatory Approval Process
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
      • 5.1.3.2. Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Integration of Microfluidics with Existing Workflows
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Material: Increasing use of glass and silicon-based materials for microfluidic devices
    • 5.2.2. Component: Adoption of microneedles and pumps for minimal risk of infection
    • 5.2.3. Application: Significant application of microfluidic devices in IVD and therapeutics
    • 5.2.4. End User: Emerging use of microfluidics in research organizations and hospitals & diagnostics centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Microfluidics Market, by Material

  • 6.1. Introduction
  • 6.2. Glass-based
  • 6.3. Polymer-based
  • 6.4. Silicon-based

7. Microfluidics Market, by Component

  • 7.1. Introduction
  • 7.2. Micro Needle
  • 7.3. Micro Pump
  • 7.4. Microfluidic Chip

8. Microfluidics Market, by Application

  • 8.1. Introduction
  • 8.2. In-Vitro Diagnostics
    • 8.2.1. Clinical Diagnostics
    • 8.2.2. Point-Of-Care Testing
    • 8.2.3. Veterinary Diagnostics
  • 8.3. Pharmaceutical & Life Science Research
    • 8.3.1. Lab Analytics
      • 8.3.1.1. Capillary Electrophoresis
      • 8.3.1.2. Cell-based Assays
      • 8.3.1.3. Genomic analysis
      • 8.3.1.4. Proteomic Analysis
    • 8.3.2. Microdispensing
    • 8.3.3. Microreaction
  • 8.4. Therapeutics
    • 8.4.1. Drug Delivery
    • 8.4.2. Wearable Devices

9. Microfluidics Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals & Diagnostic Centers
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Microfluidics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Microfluidics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Microfluidics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform
    • 13.3.2. Bio-Techne to acquire Swiss spatial biology firm Lunaphore
    • 13.3.3. CellFE Announces Launch of Novel Microfluidic Cellular Engineering Platform at ASGCT 2023 Annual Meeting

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Ascent Bio-Nano Technologies, Inc.
  • 3. Camozzi Automation S.p.A.
  • 4. Dolomite Microfluidics
  • 5. IMT Masks and Divisions AG
  • 6. PerkinElmer Inc.
  • 7. Thermo Fisher Scientific, Inc.
  • 8. Mission Bio, Inc.
  • 9. Idex Corporation
  • 10. NanoCellect Biomedical.
  • 11. Abaxis, Inc.
  • 12. Quidel Corporation
  • 13. Koninklijke Philips N.V.
  • 14. Parker-Hannifin Corporation
  • 15. Illumina, Inc.
  • 16. Bio-Rad Laboratories, Inc.
  • 17. BioFluidica
  • 18. Agilent Technologies, Inc.
  • 19. Danaher Corporation
  • 20. Biosurfit SA
  • 21. SMC Corporation
  • 22. Micropoint Bioscience, Inc.
  • 23. Fluigent S.A.
  • 24. Elvesys Group
  • 25. Achira Labs Pvt. Ltd.
  • 26. Sphere Fluidics Limited
  • 27. OPKO Health, Inc.
  • 28. Cellix Limited
  • 29. AbCellera Biologics Inc.
  • 30. Fluidigm Corporation by Standard BioTools Inc.

LIST OF FIGURES

  • FIGURE 1. MICROFLUIDICS MARKET RESEARCH PROCESS
  • FIGURE 2. MICROFLUIDICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MICROFLUIDICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MICROFLUIDICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MICROFLUIDICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MICROFLUIDICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MICROFLUIDICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MICROFLUIDICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MICROFLUIDICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MICROFLUIDICS MARKET DYNAMICS
  • TABLE 7. GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MICROFLUIDICS MARKET SIZE, BY GLASS-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MICROFLUIDICS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MICROFLUIDICS MARKET SIZE, BY SILICON-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRO NEEDLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRO PUMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICROFLUIDIC CHIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MICROFLUIDICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MICROFLUIDICS MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MICROFLUIDICS MARKET SIZE, BY VETERINARY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MICROFLUIDICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MICROFLUIDICS MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MICROFLUIDICS MARKET SIZE, BY GENOMIC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MICROFLUIDICS MARKET SIZE, BY PROTEOMIC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRODISPENSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICROREACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL MICROFLUIDICS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL MICROFLUIDICS MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL MICROFLUIDICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL MICROFLUIDICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. SINGAPORE MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. TAIWAN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. THAILAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. VIETNAM MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. FINLAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. FRANCE MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. GERMANY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 243. ISRAEL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. ITALY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. NIGERIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. NORWAY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 283. POLAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 291. QATAR MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 292. QATAR MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 299. RUSSIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 300. RUSSIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 308. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 316. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 323. SPAIN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 324. SPAIN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 331. SWEDEN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 332. SWEDEN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 333. SWEDEN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 340. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 346. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 347. TURKEY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 348. TURKEY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 349. TURKEY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 350. TURKEY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 351. TURKEY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 352. TURKEY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 353. TURKEY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 354. TURKEY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 355. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 356. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)

TABLE